Scientists at Israel’s Weizmann Institute have found that treating melanoma with immunotherapy is only successful if the cancer cells are homogeneous (simple / comprised of a small number of subtypes). Other treatments should be used if they are heterogeneous (complex … Continue reading →

Israel has launched the Israel Precision Medicine Partnership –  an innovative $60 million program to enable researchers to target the best treatments for a patient’s disease (e.g. cancer). Precision medicine uses genetic sequencing to predict an individual’s response to specific … Continue reading →